Aptevo Therapeutics Inc.
$2.37
-0.05 (-2.27%)
Price as of Aug 28, 2026 market close
Performance
- 1 Month
- -42.7%
- 3 Months
- -51.8%
- YTD
- -74.9%
- 1 Year
- -92.7%
Price return, based on split- and dividend-adjusted closing prices.
Risk
- Volatility 1-year annualized
- 98.6%
- Largest decline max drawdown, since Aug 2025
- -93.7%
- Risk-adjusted return Sharpe ratio, 1-year
- -2.14
Own APVO?
See how APVO contributes to your portfolio's return, allocation, and risk.
7-day free trial, then $9/month.